Komori
Immuno-Biological Laboratories (4570) · TargetMitigated

Improving the repeat-purchase rate among cosmetics members

First written in FY2016. 2 of 5 entries say "Restated". Latest entry: FY2025.

5entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseWorsenedFY20172016: 220162017: 220172018: 020182019: 020192020: 020202021: 020212022: 020222023: 020232024: 020242025: 12025
Same theme, other companies
Fundamental Reform of the Cosmetics Business and Expansion of Brands and Sales ChannelsA theme 24 companies write about · 1 as a headwind · 31 as a tailwind

The whole theme swung hardest in 2017: 2 of 13 companies on the "Worse" side.

0 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 24 companies compared. The sentences above are computed from all 24.
Full recordFilings, disclosures and news, newest first
  1. FY2025MitigatedAnnual report

    「The high retention rate among subscription customers and a slight increase in new customers lifted revenue to ¥5.160 million, up 34.0% year on year.」

    The company had previously reported that it could not acquire repeat customers and that revenue had declined, but this time explained that the retention rate among subscription customers was high and that new customers had also increased slightly.
  2. FY2017WorsenedAnnual report

    「The business continued outbound activities, including direct mail and telephone calls, targeting new customers acquired through advertising, but was unable to acquire repeat customers, resulting in lower revenue.」

    Although advertising and outbound activities continued, the company could not acquire repeat customers, resulting in lower revenue.
  3. FY2017-Q3RestatedAnnual report

    「From the second quarter, this business has been conducting efficient advertising activities to acquire new customers. It is also continuing outbound activities, including direct mail and telephone calls, to acquire repeat customers.」

    The company has continued efficient advertising activities and outbound efforts through direct mail and telephone calls since the second quarter.
  4. FY2017-Q1RestatedAnnual report

    「From the second quarter onward, the company will implement efficient advertising activities and continue direct-mail and outbound activities, including telephone calls, to acquire new members and improve the repeat-purchase rate among members.」

    The company plans to acquire new members and improve the repeat-purchase rate through advertising and outbound initiatives from the second quarter onward.
  5. FY2016First statedAnnual report

    「The company will continue working to improve the repeat-purchase rate among its members.」

    For cosmetics mail-order sales, the company indicated that it aims to increase continued use of its membership base.
Moved together

"Narrowing Operating Losses and Continued Losses" moved the same way as this thread, in the same document, in 2 of its 5 moves.

222★123
  1. ★This thread
  2. 1Narrowing Operating Losses and Continued Losses2×
  3. 2Risk of losses and deterioration in operating cash flow associated with strengthening basic research2×
  4. 3Risk of impairment of fixed assets due to declining profitability2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Immuno-Biological Laboratories yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.